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     BSTRACT
Between April 2012 and July 2015, cloacal and/or tracheal swab samples were collected from four 
hundred and twenty-four Belgian chicken broiler, breeder and layer flocks. All flocks were kept for 
production purposes and presented clinical signs suggestive of an infectious bronchitis virus (IBV) 
infection. The samples were analyzed by real-time polymerase chain reaction (RT-qPCR) to detect 
the presence of ribonucleic acid (RNA) of IBV. When positive, approximately four hundred base pairs 
(bp) encoding for the hypervariable region of the IBV S1 protein were sequenced. Sequencing results, 
cycle threshold (Ct) values and vaccination history were used as criteria to try and distinguish vaccine 
strains from field strains. 
Of all samples examined, 22.4% was negative. In 16.4% of the samples that did contain RNA 
from IBV, the genotype could not be determined. In most cases, this was due to the recovery of 
RNA quantities below the lower limit of detection of the sequencing PCR. The remaining positive 
submissions predominantly revealed RNA from IBV strains that belonged to the 4/91–793B (46.8%), 
D388–QX (25.2%), D274-D207 (5.8%) and Massachusetts (4.0%) genotypes. Estimations indicated 
that approximately 58%, 11%, 37% and 46% of these detections, respectively, were vaccine strains. 
Infections with types CK/CH/Guandong/Xindadi/0903, Ukr/27/2011, NGA/295/2006 and Q1 were 
observed sporadically.
The results indicate that IBV infections are highly prevalent in Belgian chickens and that at least 
eight different IBV types were circulating during the monitored period. This underlines the necessity 
of providing flocks with a strong and broad protective immunity against IBV. 
SAMENVATTING
Tussen april 2012 en juli 2015 werden swabs genomen uit de cloaca en/of trachea bij 
vierhonderdvierentwintig tomen Belgische kippen, zowel vleeskuikens, ouderdieren als leghennen. Alle 
tomen werden voor commerciële doeleinden gehouden en ze vertoonden klinische symptomen die konden 
wijzen in de richting van een infectieuze bronchitisvirus (IBV)-infectie. De monsters werden onderzocht via 
“real-time polymerase chain reaction” (RT-qPCR) om de aanwezigheid van ribonucleïnezuur (RNA) van 
IBV na te gaan. Wanneer ze positief bleken, werd een sequenering uitgevoerd van ongeveer vierhonderd 
baseparen (bp) die coderen voor de hypervariabele regio van het S1-proteïne. De gevonden sequenties, 
de “cycle treshold” (Ct)-waarden en het toegediende entschema werden gebruikt om de veldstammen en 
vaccinstammen van elkaar te kunnen onderscheiden.
Van alle onderzochte monsters was 22,4% negatief. In 16,4% van de monsters waarin RNA van IBV 
aanwezig was, kon het genotype niet bepaald worden. Dit was vooral omdat de hoeveelheid RNA lager was 
dan de onderste detectiegrens van de sequeneringsPCR. In de  overige positieve monsters werd vooral RNA 
van IBV-stammen die behoorden tot de genotypes  4/91–793B (46,8%), D388–QX (25,2%), D274-D207 
(5,8%) en Massachusetts (4,0%) aangetroffen. Schattingen duidden erop dat respectievelijk ongeveer 
58%, 11%, 37% en 46% van de aangetoonde virussen, vaccinstammen waren. Infecties met types CK/CH/
Guandong/Xindadi/0903, Ukr/27/2011, NGA/295/2006 en Q1 werden occasioneel gevonden. 
De resultaten tonen aan dat IBV-infecties bij kippen in België frequent voorkomen en dat in de 
gemonitorde periode minstens acht IBV-types circuleerden. Dit bevestigt de noodzaak om kippentomen te 
voorzien van een sterke en breed beschermende immuniteit tegen IBV.
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INTRODUCTION
Infectious bronchitis virus (IBV) is the cause of a 
very common and economically important disease in 
chickens. In young birds, IBV mostly leads to respira-
tory problems although some strains are nephropatho-
genic. Mortality in infected flocks may rise to 30%. In 
layer and breeder chickens, egg production and qual-
ity declines are observed.
IBV was first recorded in 1931 in Massachusetts 
(Schalk and Hawn, 1931). This original IBV was 
therefore called the Massachusetts type. Being a single 
stranded RNA virus, IBV appeared highly susceptible 
to mutation. Variations in the S1 spike protein, which 
is localized on the surface of the virus particles, have 
led to the emergence of numerous variants worldwide 
(Jackwood and de Wit, 2014). Vaccines may afford 
variable protection against variants, which may ham-
per control of the disease by vaccination. Formerly, 
variants were identified on the basis of virus neutral-
ization assays (serotyping) but nowadays, these tests 
have been replaced by molecular techniques (genotyp-
ing).
The situation with respect to IB prevalence and 
IBV types involved in infection may easily change 
over time (de Wit et al., 2011a). As such, epidemio-
logical surveys in the Belgian poultry sector demon-
strated a clear shift from types that occurred during 
a first period of monitoring between 1986 and 1995 
(Meulemans et al., 2001) and a second monitored pe-
riod from 2002 to 2006 (Worthington et al., 2008). 
More recent information has not been well collated. 
Therefore, it was the aim of the present study to ex-
amine the current prevalence of IB in Belgian chicken 
flocks and to identify the IBV types involved.
MATERIALS AND METHODS
Flock data and sampling
From April 2012 to July 2015, veterinary practitio-
ners submitted samples from 181 broiler, 139 broiler 
breeder and 104 layer chicken flocks. All flocks were 
kept for production purposes and exhibited signs that 
might indicate an IBV infection, such as respiratory 
disorders, wet litter, drops in egg production and egg-
shell deformities. Submissions were always accompa-
nied by a completed questionnaire gathering detailed 
information on the date and site of sampling, the type 
and age of sampled birds, the clinical signs and lesions 
observed and the vaccination history (products used, 
age and route of administration and dosing).
For each flock, ten dry swabs were taken from the 
cloaca and/or trachea of the birds, put in individual 
plastic tubes and sent to the diagnostic laboratory. The 
interval between collection of samples and laboratory 
examination was approximately two weeks. Except 
during transport, the samples were stored between 2 
and 8 °C.
Molecular analyses
In order to confirm the presence of RNA from IBV 
(regardless of genotype) in the submitted samples, 
the real-time polymerase chain reaction (RT-qPCR) 
method described by Callison et al. (2006) was ap-
plied to ten swab sample pools. Up to 35 cycles were 
run. The cycle threshold (Ct) value was noted in posi-
tive samples that were further analyzed using univer-
sal primers specific for the S1 region of the IBV ge-
nome as well as an additional primer pair appropriate 
Table 1. Results of screening for the presence of IB viruses from April 2012 to July 2015 in Belgian chicken flocks 
exhibiting clinical signs, through RT-qPCR and sequencing analyses.
  
 Complete collection of  Samples obtained from flocks of
 
 samples Broilers Breeders Layers
Number of flocks tested 424 181 139 104
Result of RT-qPCR analysis     
    % IBV positive 77.6 84.0 74.8 70.2
    % IBV negative 22.4 16.0 25.2 29.8
Genotype distribution (%) of positive samples     
 
    4/91 – 793B 46.8 56.6 37.5 39.7
    D388 – QX 25.2 32.9 11.5 28.7
    D274 – D207 5.8 2.6 14.4 0
    Massachusetts 4.0 3.3 4.8 4.1
    CK/CH/Guandong/Xindadi/0903 0.9 0 1.9 1.4
    Ukr/27/2011 0.3 0 0 1.4
    Q1 0.3 0 1.0 0
    NGA/295/2006 0.3 0 1.0 0
    Untypeable 16.4 4.6 27.9 24.7
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for the detection of the D1466 genotype (Cavanagh 
et al., 1999; Worthington et al., 2008). This generated 
a PCR product of approximately 400 base pairs (bp) 
encoding the hypervariable region of the S1 protein 
for sequencing. Sequencing was conducted accord-
ing to Worthington et al. (2008), with slight modifica-
tions. Obtained sequences were compared with those 
available in the NCBI Genbank nucleotide database in 
order to determine the IBV genotype involved. 
Distinction between field strains and vaccine 
strains
Up to present, an in vitro method that allows the 
unambiguous distinction between field viruses and 
vaccine viruses of the same genotypes, does not exist. 
Live vaccine strains often used in Belgian poultry 
belong to the genotypes Massachusetts, 4/91 - 793B 
(Cook et al., 1996; Gough et al., 1992), D388 – QX 
(Beato et al., 2005; de Wit et al., 2011b; Landman et 
al., 2005; Toffan et al., 2011; Yu et al., 2001) and D274 
– D207 (Davelaar et al., 1984; Jordi et al., 1989). In 
order to estimate the proportion of field viruses in 
samples that contained RNA from these genotypes, 
multiple criteria were used.
First, the sequence of the detected viruses was 
compared to corresponding sequences in an internal 
database built by examining vials of all common com-
mercial vaccines through next generation sequencing 
(X-Ovo Limited, unpublished). Sequences were also 
compared to those obtained in vaccinated flocks in 
other countries where no field strains equivalent to 
the vaccine genotype were known to circulate. The 
criteria proposed by Worthington et al. (2006) were 
used for evaluation of the results. For viruses with 
100% sequence homology to the vaccine strains, it 
was considered most probable they were indeed vac-
cine strains. Less than 99% homology may have been 
a field challenge while the intermediate range was 
considered questionable. 
As a second criterion, obtained Ct values were com-
pared to Ct values established during serial monitoring 
in vaccinated and infected flocks under field and experi-
mental conditions. When the measured Ct value was 
significantly lower than expected, this could constitute 
an additional argument for the involvement of a field 
virus. Especially Ct values below 20 - demonstrating 
a large amount of viral RNA in the samples - were 
considered indicative for a field virus infection. 
Also the vaccination history was taken into ac-
count; the identity of the vaccines used as well as the 
eventual interval between their administration and 
the sampling of the birds contributed to the evalua-
tion. Finding the sequence of a genotype that was not 
included in the vaccination schedule or finding a se-
quence in vaccinated flocks at a much later moment 
than could be expected from experiments and field 
experiences, were considered possible indicators of a 
field infection.
After evaluating the degree of evidence provided 
Table 2. Proportion (%) of RT-qPCR positive samples that showed either 100%, between 99 % and 100% or less than 
99 % identity with commercially available vaccine strains, on the basis of sequencing analyses of the hypervariable 
region encoding the IBV S1 protein.
 IBV genotype  Sequence identity to homologous vaccine strains 
 
  100 % 99 % – 100 % < 99 %
   
4/91 – 793B 64.3 17.5 18.2
D388 – QX 10.8 54.2 35.0
D274 – D207 31.6 52.6 15.8
Massachusetts 38.5 38.5 23.0
Table 3.  Overview of presumed field strains of IBV demonstrated in Belgian chicken flocks between April 2012 and 
July 2015 (*).
IBV genotype Percentage  Number of isolates obtained from
 of total number of isolates Broilers Breeders Layers
    
D388 – QX 44.8 % 42 11 21
4/91 – 793B 40.0 % 14 27 25
D274 – D207 7.3 % 1 11 0
Massachusetts 4.2 % 1 4 2
CK/CH/Guandong/Xindadi/0903 1.8 % 0 2 1
Ukr/27/2011 0.6 % 0 0 1
Q1 0.6 % 0 1 0
NGA/295/2006 0.6 % 0 1 0
(*) Presumed to be field strains on the basis of their S1 sequence homology, PCR Ct values and vaccination history.
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by the outcome of the three criteria, the detected vi-
ruses were classified as presumed field strains or pre-
sumed vaccine strains. 
RESULTS
The results of molecular screening in 424 Belgian 
chicken flocks from April 2012 to July 2015 are sum-
marized in Table 1, Table 2 and Table 3.
Overall 22.4 % of the 424 examined flocks did not 
reveal any RNA from IBV and was therefore consid-
ered negative. The remaining 77.6% of the samples 
appeared IBV positive (Table 1).
In 16.1 % of the positive samples, it was impos-
sible to classify the detected viruses into a specific 
genotype. Untypeable strains were found mostly in 
samples with a very high Ct, indicating they contained 
only a very small quantity of RNA, insufficient for 
appropriate sequencing. In the remaining 83.9 % of 
IBV positive samples, the detected viruses could be 
attributed to eight different genotypes (Table 1).
Strains belonging to the genotypes 4/91 - 793B, 
D388 – QX, D274 – D207 and Massachusetts were 
most prevalent, accounting for approximately 98% of 
all typeable detections. For these genotypes, 64.3%, 
10.8%, 31.6 and 38.5% of the strains, respectively, 
showed 100% identity with homologous vaccine 
strains (Table 2). 
The variant type 4/91 - 793B was found in 46.8 % 
of the IBV positive samples. It was estimated that this 
type was involved in approximately 40% of the IBV 
field infections. Presumed field strains were found 
most often in breeder and in layer flocks.
D388 – QX strains of IBV represented 25.2 % of 
the IBV-positive cases. They were considered respon-
sible for approximately 45% of all IBV field infec-
tions, predominantly in broiler flocks.
Variant type D274 – D207 strains accounted for 
5.8 % of the positive samples, approximately 37% of 
which were vaccine. Presumed field strains were demon- 
strated almost exclusively in breeder flocks. 
Classical Massachusetts strains were found in 4 % 
of the IBV positive flocks; rather even proportions 
were derived from broilers, breeders and layers. Pre-
sumed field infections occurred especially in breeder 
flocks and sporadically in layer birds.
Other genotypes were found sporadically. Three 
strains belonged to the variant type CK/CH/Guandong/
Xindadi/0903 (Ji et al., 2011); it was obtained twice 
from breeders and once from layers. The variant type 
UKR/27/2011 (Ovchinnikova et al., 2012) was found 
only once in a layer flock. Variants NGA/295/2006 
(Ducatez et al., 2009) and Q1 (Toffan et al., 2011; Liu 
and Kong, 2004; Yu et al., 2001) were also just found 
once, both in breeders. 
Comparing the amino acid composition of the ex-
amined part of the S1 protein between possible field 
strains and homologous vaccine strains (when avail-
able), an average homology of 97.5% was found. Only 
2 % of the detections showed less than 90% homo-
logy, extending as low as 72% in one QX-type strain.
DISCUSSION
Molecular techniques are appropriate to run epi-
demiological studies on IBV infections in chickens, 
including the identification of IBV types involved 
(Worthington et al., 2008), on a large scale. Additional 
advantages are that they can be performed on dry swab 
samples that are taken in a non-invasive way from live 
birds and that these can be sent to the lab without tak-
ing special precautions to storage and/or shipment 
conditions (Cavanagh et al., 1999; Worthington et al., 
2008). These techniques therefore were suitable to the 
purpose of the present study. 
In order to obtain clear insights in the epidemio-
logical situation, field strains have to be distinguished 
from live homologous vaccine strains. No standard-
ized method for achieving this differentiation of strains 
exists (Jackwood and de Wit, 2014; Worthington et al., 
2008). In an attempt to distinguish field and vaccine 
strains, some authors have compared the sequence of 
genes encoding the S1 protein from obtained isolates 
with the sequence of vaccine strains (Worthington et 
al., 2008). However, this only gives unambiguous re-
sults in case of extensive sequence differences. Live 
IBV vaccines are usually obtained after serial passag-
ing of IBV field strains in vitro. This procedure leads 
to attenuation but not necessarily to significant dif-
ferences in the S1 composition, meaning that some 
vaccine strains may show virtually 100% homology 
to field strains for the composition of the S1 protein 
(Huang and Wang, 2007). Further, vaccine strains 
might –just as it is observed in field strains- sporadi-
cally undergo mutation for the S1 protein under field 
circumstances. Isolates with slight S1 deviations 
compared to vaccine strains thus do not necessarily 
indicate field viruses. This should be kept in mind, es-
pecially when encountering isolates that are different 
from the vaccine strains in only one or a few nucleo-
tides. Thus, although sequencing is often appropriate 
for the classification of isolates into field or vaccine 
strains, it cannot attribute all isolates in an undisputed 
way. In order to enhance the reliability of the clas-
sification method, in this study, additional evaluation 
criteria were used, namely the Ct value of the samples 
in RT-qPCR and the vaccination history of the birds. 
Although it cannot be excluded that in some cases 
vaccine strains and field strains have been confused, 
this way of working was suitable to provide insights 
in the overall IBV situation of chickens in Belgium. A 
basic difference between field and vaccine strains is 
their virulence. An in vitro test determining virulence 
of IBV strains would therefore be a useful tool for dis-
tinguishing field and vaccine strains, especially when 
they are having a very high degree of S1 homology. 
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Virulence mechanisms in IBV are however poorly un-
derstood (Jackwood and de Wit, 2014). Armesto et al. 
(2009) have demonstrated experimentally that activity 
of the replicase gene may be of importance but more 
research in this field is needed.
At the time this study was initiated, published data 
on IBV infections in Belgian chicken flocks were 
scarce. Data obtained by Meulemans et al. (2001) 
related to the period 1986-1995 and the situation in 
broilers only. Worthington et al. (2008) organized a 
more recent study between 2002 and 2006 but it is 
unclear whether or not their examinations related to 
all categories of chickens. Despite some limitations, 
comparing these authors’ results with the present ones 
showed clear changes over time. Indeed, as Massachu-
setts and D274-D207 were the most prominent types 
up to the mid-nineties, their prevalence has continu-
ously declined to become rather occasional findings at 
present. The B1648 variant (Meulemans et al., 1987), 
which accounted for 11% of the isolates collected be-
tween 1986 and 1995, was not recovered in the sub-
sequent surveys. On the other hand, the prevalence 
of the 4/91 – 793B type, which was observed origi-
nally in less than 1% of the cases, has continuously 
increased to become involved nowadays in approxi-
mately 40 % of the IBV field infections in Belgium, 
especially in breeders and layers. The type D388 – QX 
first appeared in Belgium in 2004 (personal observa-
tions) and quickly became the primary IBV type caus-
ing problems at present, especially in broilers.
Besides the major types of IBV mentioned above, 
several others may sporadically occur in Belgium. As 
such, Worthington et al. (2008) reported the Italy02 
(Jones et al., 2005) and D1466 (Davelaar et al., 1984) 
variants in 1.9% and 4.4% of the cases, respectively. 
These strains were not encountered in the present sur-
vey. CK/CH/Guandong/Xindadi/0903, Ukr/27/2011, 
Q1 and NGA/295/2006 variants were documented 
but none of them accounted for more than 2% of the 
isolates. A possible explanation for the fact that these 
variants do not expand could be that currently used 
vaccination schemes provide protection against them. 
This can be supported by the fact that infected flocks 
showed only low virus loads, most probably indica-
ting that the infections were not significantly related to 
the problems in the flocks and thus were coincidental 
findings. Further, experimental challenge data (de Wit 
et al., 2014 ; Massi et al., 2006) have demonstrated a 
high level of protection against Q1 and Italy02 vari-
ants in chickens vaccinated according to the protecto-
type approach proposed by Cook et al. (1999), a vac-
cination concept which is often practized in Belgium. 
Briefly, improved protection can be achieved against 
many IBV strains by using a combined vaccination 
programme incorporating two antigenically differ-
ent IBV vaccines, as it has been amply elaborated for 
Massachusetts and 4/91 vaccine strains (Cook et al., 
1999 ; Cook et al., 2001 ; de Wit et al., 2014 ; Ter-
regino et al., 2008). 
In the past, IBV strains were classified through 
serotyping. This was done by examining the reac-
tion pattern of isolates with reference antisera in 
virus neutralization tests. Nowadays, serotyping has 
largely been abandoned and replaced by genotyping. 
Genotypes are defined mostly on the basis of genome 
sequences encoding the IBV S1 protein. For most iso-
lates, serotyping and genotyping lead to the same out-
come but exceptions may occur, as demonstrated by 
Majó et al. (2004). It has been suggested (Jackwood 
and de Wit, 2014) that different results in serotyping 
and genotyping are found especially when the level 
of S1 amino acid homology of an isolate compared 
to the reference strain, drops below 90%. In the pres-
ent study, the percentage of homology between field 
strains and reference vaccine strains was below 90% 
in 2 % of the cases, at least for the examined S1 frag-
ment. For one of the strains, the homology reached 
only 72%. It would be interesting to examine these 
strains further through serotyping and in experimen-
tal challenge trials as this could indicate whether mu-
tations relevant to protective immunity building are 
present.
The results of the present study indicate that IBV 
infections are highly prevalent in Belgian commercial 
chicken flocks. At least eight types of IBV appeared 
to be circulating in the past three years. This under-
lines the necessity of providing chickens with a strong 
vaccinal immunity against IBV. A broad protection 
against a wide range of IBV types can be obtained by 
applying vaccines according to the protectotype con-
cept (Cook et al., 1999). 
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